written on 24.11.2015
Days to Grant Registration for Innovative Drugs in Mexico
Similar Facts and Figures
Mexico Pharma Market Forecast 2020
Become a PharmaBoardroom Member for free to access this contentJoin the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Email Address Password…
Top 10 Pharma Companies in Mexico
Become a PharmaBoardroom Member for free to access this contentJoin the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Email Address Password…
Mexican Pharmaceutical Factsheet
Become a PharmaBoardroom Member for free to access this contentJoin the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Email Address Password…
The Mexican Medical Device Industry: Manufacturing Costs and Exports
Become a PharmaBoardroom Member for free to access this contentJoin the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Email Address Password…
Mexico Facts and Figures Snapshot
Become a PharmaBoardroom Member for free to access this contentJoin the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Email Address Password…
Growth of the Mexican market in units and volume
Become a PharmaBoardroom Member for free to access this contentJoin the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroomRegisterAlready a member? Sign In Log into your account Email Address Password…
Latest Report
Mexico / India Ties Deepen; Lilly COVID Drugs Approved; Lithium Opportunities
The latest from Mexican pharma, including government talks with Indian authorities to provide low-cost medicines, a new distribution pilot program led by the military, the authorization of two Lilly monoclonal…
LatAm / Aligning Stakeholder Partnerships: Best Practices from Cuba & Mexico
Writing in the November issue of DIA Global Forum, Lawrence Liberti, Mario Alanis, Pravin Chopra, and Silvia Bendiner examine how the COVID-19 pandemic facilitated greater inter-stakeholder collaboration across the healthcare…
LatAm / Bayer Bets Big in Costa Rica/Argentina; Mexico Drug Approvals Slow; Pfizer’s Aggressive Supply Deal Tactics
The latest from the healthcare industry in Latin America, including an alarming OECD report about the decline of well-being in the region due to Covid-19, Bayer’s USD 350 million investment…